Early use of tocilizumab in patients with severe pneumonia secondary to severe acute respiratory syndrome coronavirus 2 infection and poor prognostic criteria: Impact on mortality rate and intensive care unit admission

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, keeps spreading globally. Evidence suggests that a subgroup of patients with severe symptomatology might have cytokine storms, which increases mortality. The use of interleukin-6 (IL-6) inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Rovira, Pedro, Pérez-Chica, Gerardo, Ortega-Granados, Ana Laura, Aguilar-García, Josefa, Díaz-Beltrán, Leticia, Gálvez-Montosa, Fernando, García-Verdejo, Francisco, Luque-Caro, Natalia, Quero-Blanco, Cristina, Fernández-Navarro, Mónica, Rodríguez-Sánchez, Agustín, Ruiz-Bailén, Manuel, Yaguez-Mateos, Luis, Marín-Pozo, Juan Francisco, Sierra-Torres, María Isabel, Lacárcel-Bautista, Celia, Duro-Ruiz, Gaspar Jesús, Duro-Fernández, María Ángeles, García-Alegría, Javier, Herrero-Rodríguez, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294903/
https://www.ncbi.nlm.nih.gov/pubmed/34398008
http://dx.doi.org/10.1097/MD.0000000000026533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294903/
https://www.ncbi.nlm.nih.gov/pubmed/34398008
http://dx.doi.org/10.1097/MD.0000000000026533

Ejemplares similares